By Stellamaries Amuwa, Abuja
European Union (EU), through the Commissioner, Jutta Urpilainen, has pledged to continue to invest in common future and priotise security, democracy and prosperity.
Speaking at the signing of Financing Agreements of Nigeria-EU Development Projects and EU-Nigeria Strategic Meeting Thursday at the Banquet Hall, Presidential Villa, Abuja.
Urpilainen reiterated that the EU will continue to invest in Nigeria in security and democracy which will promote common future for both Nigeria and the European Union.
Urpilainen said, “I look forward to launching a package of new actions, as part of the Global Gateway strategy and EU support to Government priorities.
“Building on our long-standing cooperation, and in the best spirit of shared responsibility, commitment and accountability, the EU will continue to invest in our common future and priorities of security, democracy and prosperity for all – not least through the package of loans and grants I am signing and launching here today that will benefit the Nigerian businesses, farmers, youth and the society a as whole.”
Meanwhile, the Minister of Budget and Economic Planning, Abubakar Atiku Bagudu, announced together with Urpilainen unveiled a financial package for a total of over €900 million (₦728 billion) with Team Europe.
This major package forms a central part of the EU-Nigeria cooperation to advance the country’s green, resilient, digital inclusive transition under government priorities and Global Gateway, the EU’s positive offer to deliver sustainable and trusted connections with partner countries.
The minister said, “The EU-Nigeria Strategic Dialogue is happening at the take-off of the current Administration in Nigeria and presents opportunities for proper articulation and consolidation of priorities in our Partnership.
“I am very happy to announce today two financial agreements in crucial sectors for Nigeria and the region: health and entrepreneurship. The partnership with EMZOR pharmaceutical Industries is a significant step towards accelerating treatments against malaria and healthcare access across the region while reducing the dependence on the importation of essential medicines. We are proud to accompany the development of a pioneer firm committed to strengthening the antimalarial supply chain and production.
